Seeking Alpha

Alnylam Pharmaceuticals (ALNY) is in discussions with "more than one" potential partner to help...

Alnylam Pharmaceuticals (ALNY) is in discussions with "more than one" potential partner to help it carry out Phase II and Phase III studies of its ALN-PCS treatment for high cholestoral, CEO John Maraganore says, although he declines to name names.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs